D
37
-6
XOM
48
-12
MCO
65
3
MCK
63
-3
EXPE
83
2
NRG
52
-8
AVY
50
3
PYPL
52
3
LMT
50
3
CMCSA
32
-10
HD
43
2
MDT
60
-3
WDC
66
3
DE
45
-3
PFG
67
2
URI
40
-3
STX
66
4
SHW
53
-2
NOV
55
-3
DOV
71
2
D
37
-6
XOM
48
-12
MCO
65
3
MCK
63
-3
EXPE
83
2
NRG
52
-8
AVY
50
3
PYPL
52
3
LMT
50
3
CMCSA
32
-10
HD
43
2
MDT
60
-3
WDC
66
3
DE
45
-3
PFG
67
2
URI
40
-3
STX
66
4
SHW
53
-2
NOV
55
-3
DOV
71
2
Financhill
Back

Kuros Biosciences Ltd. 10K Form

Sell
49

CSBTF
Kuros Biosciences Ltd.

Last Price:
$38.15
Seasonality Move:
16.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CSBTF News And Ratings

See the #1 stock for the next 7 days that we like better than CSBTF

CSBTF Financial Statistics

Sales & Book Value

Annual Sales: $85.8M
Cash Flow: $0
Price / Cash Flow: 543.07
Annual Sales: $1.72
Price / Book: 20.91

Profitability

EPS (TTM): -0.18420
Net Income (TTM): $-6.4M
Gross Margin: $75.5M
Return on Equity: -6.35%
Return on Assets: -4.79%

Kuros Biosciences Ltd. Earnings Forecast

Key Kuros Biosciences Ltd. Financial Ratios

  • The Gross Profit Margin over the past 24 years for CSBTF is 87.98%.
  • The Selling, General & Administrative Expenses for CSBTF have been equal to 79.62% of Gross Profit Margin.
  • The Research & Development expenses have been 9.24% of Revenue.
  • The Net Earning history of CSBTF is -4.92% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 15 years.

Kuros Biosciences Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: CSBTF
Website: kurosbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.14
Quick Ratio: 1.61

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CSBTF Technical Analysis vs Fundamental Analysis

Sell
49
Kuros Biosciences Ltd. (CSBTF) is a Sell

Is Kuros Biosciences Ltd. a Buy or a Sell?